ES2092206T3 - Medicamentos que contienen un compuesto de imidazol-1-ilo. - Google Patents

Medicamentos que contienen un compuesto de imidazol-1-ilo.

Info

Publication number
ES2092206T3
ES2092206T3 ES93118167T ES93118167T ES2092206T3 ES 2092206 T3 ES2092206 T3 ES 2092206T3 ES 93118167 T ES93118167 T ES 93118167T ES 93118167 T ES93118167 T ES 93118167T ES 2092206 T3 ES2092206 T3 ES 2092206T3
Authority
ES
Spain
Prior art keywords
ilo
imidazole
compound
medicines containing
anomalies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93118167T
Other languages
English (en)
Inventor
Christian Eeckhout
Ulf Preuschoff
Samuel David
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Kali Chemie Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma GmbH filed Critical Kali Chemie Pharma GmbH
Application granted granted Critical
Publication of ES2092206T3 publication Critical patent/ES2092206T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE DESCRIBE LA UTILIZACION DE COMPUESTOS IMIDAZOL-1-ILO DE LA FORMULA GENERAL I DONDE R1 SIGNIFICA ALQUILO INFERIOR O HIDROGENO, M ES 2 O 3 Y N ES 2 O 3, Y SUS SALES DE ADICION ACIDA TOLERABLES FISIOLOGICAMENTE PARA LA ELABORACION DE PREPARACIONES FARMACEUTICAS PARA EL TRATAMIENTO DE TRASTORNOS FUNCIONALES UNIDOS A SENSIBILIDAD DOLOROSA ELEVADA Y/O ANOMALIAS DEL PASO EN LA ZONA DEL COLON DE LAS VIAS INTESTINALES INFERIORES EN MAMIFEROS GRANDES Y SERES HUMANOS.
ES93118167T 1992-11-14 1993-11-10 Medicamentos que contienen un compuesto de imidazol-1-ilo. Expired - Lifetime ES2092206T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4238553A DE4238553A1 (de) 1992-11-14 1992-11-14 Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ES2092206T3 true ES2092206T3 (es) 1996-11-16

Family

ID=6472938

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93118167T Expired - Lifetime ES2092206T3 (es) 1992-11-14 1993-11-10 Medicamentos que contienen un compuesto de imidazol-1-ilo.

Country Status (23)

Country Link
US (1) US5438068A (es)
EP (1) EP0601345B1 (es)
JP (1) JP3683286B2 (es)
KR (1) KR100266715B1 (es)
CN (1) CN1041053C (es)
AT (1) ATE143597T1 (es)
AU (1) AU667243B2 (es)
CA (3) CA2538177A1 (es)
CZ (1) CZ284154B6 (es)
DE (2) DE4238553A1 (es)
DK (1) DK0601345T3 (es)
DZ (1) DZ1726A1 (es)
ES (1) ES2092206T3 (es)
GR (1) GR3021230T3 (es)
HU (1) HU213506B (es)
IL (1) IL107454A (es)
MX (1) MX9307079A (es)
NO (1) NO303926B1 (es)
NZ (1) NZ250103A (es)
PH (1) PH30702A (es)
RU (1) RU2125877C1 (es)
SK (1) SK278874B6 (es)
ZA (1) ZA938463B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
DE19813661A1 (de) * 1997-08-01 1999-02-04 Solvay Pharm Gmbh Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US7015333B2 (en) * 2002-11-18 2006-03-21 Solvay Pharmaceuticals B.V. Process for preparation of imidazolyl compounds
EP1424337A1 (en) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
BRPI0406749A (pt) * 2003-01-13 2005-12-20 Dynogen Pharmaceuticals Inc Métodos relacionados ao tratamento de distúrbios fincionais do intestino e composição farmacêutica
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0385517B1 (en) * 1985-03-14 1993-04-14 BEECHAM GROUP plc Medicaments for the treatment of emesis
ES2059491T3 (es) * 1987-06-29 1994-11-16 Duphar Int Res Derivados de indol con anillos condensados.

Also Published As

Publication number Publication date
DE59304045D1 (de) 1996-11-07
DZ1726A1 (fr) 2002-02-17
NO934090D0 (no) 1993-11-12
IL107454A0 (en) 1994-02-27
US5438068A (en) 1995-08-01
EP0601345A1 (de) 1994-06-15
HK1006537A1 (en) 1999-03-05
AU5064393A (en) 1994-05-26
CA2102960A1 (en) 1994-05-15
DK0601345T3 (da) 1996-11-18
ZA938463B (en) 1994-08-01
CZ236593A3 (en) 1994-05-18
HU213506B (en) 1997-07-28
CZ284154B6 (cs) 1998-08-12
CA2102960C (en) 2005-08-02
KR940010999A (ko) 1994-06-20
NO934090L (es) 1994-05-16
CN1041053C (zh) 1998-12-09
CA2538177A1 (en) 1994-05-15
SK123593A3 (en) 1994-09-07
SK278874B6 (sk) 1998-04-08
KR100266715B1 (ko) 2000-09-15
PH30702A (en) 1997-09-16
RU2125877C1 (ru) 1999-02-10
CA2504502A1 (en) 1994-05-15
GR3021230T3 (en) 1997-01-31
AU667243B2 (en) 1996-03-14
EP0601345B1 (de) 1996-10-02
DE4238553A1 (de) 1994-05-19
JP3683286B2 (ja) 2005-08-17
NO303926B1 (no) 1998-09-28
ATE143597T1 (de) 1996-10-15
HUT65978A (en) 1994-08-29
IL107454A (en) 1999-12-22
CN1092650A (zh) 1994-09-28
JPH06211656A (ja) 1994-08-02
MX9307079A (es) 1994-05-31
NZ250103A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
LU91223I2 (fr) Ivabradine et ses dérivés pharmaceutiquement acceptables (procoralan)
NO975663D0 (no) Semikarbazoner med CNS aktivitet og farmasöytiske preparater inneholdende de samme
DE69310602D1 (de) 3',5'-Ditertbutyl-4'-Hydroxyflavone, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzung mit Antioxidations- und Antivasokonstriktionsaktivität
TW427982B (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
DK0601345T3 (da) Lægemiddel Indeholdende en imidazol-l-yl-forbindelse
UA42819C2 (uk) Ін`єкційний та інфузійний розчин, що містить енрофлокcацин
TR199800714T2 (xx) Yeni $(3-Alkoksi-fenoksi)-etil]-dialkilamin t�revleri.
ES2143675T3 (es) Bencenosulfonil-ureas-tioureas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
GR3005101T3 (es)
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
MX9205385A (es) Perhidro-1-h-pirido(1,2-a)piracinas 2-sustituidas neurolepticas.
ATE63309T1 (de) 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel.
ATE9892T1 (de) Dibenzocycloheptenylidene und ihre verwendung in pharmazeutischen zusammensetzungen.
DE3268605D1 (en) 3,7a-diazacyclohepta(j,k)fluorene derivatives, their preparation and therapeutical use
DE59607280D1 (de) Verwendung von aminoalkoholderivaten als arzneimittel, derivate sowie verfahren zu deren herstellung
ATE181331T1 (de) Salmycine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
YU49004B (sh) LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE
TH22766A (th) อนุพันธ์ของแอมีดและยูเรียที่มีฤทธิ์ป้องกันหรือบรร?เทาอาการโรคโลหิตมีคอเลสเทอรอลมากเกินไป,การเตรียม?สารเหล่านั้นและการใช้สารเหล่านั้นเป็นยารักษาโรค
ES2103232A1 (es) Nuevos compuestos derivados de 1h-imidazol-2-metanol.
IT1254544B (it) Derivato di l-verbenone e composizioni farmaceutiche che lo contengono

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 601345

Country of ref document: ES